Acenocoumarol or warfarin: Which is the clinician’s ally?

Rao, Karthik N and Patil, Navin and Avinash, A and Hande, Manjunath H and Kunder, Sushil Kiran and Rao, Raghavendra (2016) Acenocoumarol or warfarin: Which is the clinician’s ally? Asian Journal of Pharmaceutical and Clinical Research, 9 (2). pp. 4-5. ISSN 0974-2441

[img] PDF
327.pdf - Published Version
Restricted to Registered users only

Download (309kB) | Request a copy

Abstract

Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.

Item Type: Article
Uncontrolled Keywords: Thrombosis; bleeding; antiphospholipid antibody syndrome; anticoagulant; International normalized ratio.
Subjects: Medicine > KMC Manipal > Medicine
Medicine > KMC Manipal > Pharmacology
Depositing User: KMC Library
Date Deposited: 10 Mar 2016 10:27
Last Modified: 10 Mar 2016 10:27
URI: http://eprints.manipal.edu/id/eprint/145526

Actions (login required)

View Item View Item